Disrupted NAD+ metabolism and kynurenine contribute to HD pathogenesis; NAD+-dependent enzymes such as SIRTs, PARPs, and SARM1, further implicated in HD progression; oxidative stress and elevated ROS, exacerbate disease by driving excess NAD+ consumption through PARP and SIRT activation. Here, PARP1 is linked to Huntington disease.